Endocyclophotocoagulation (ECP) is a well-established minimally invasive glaucoma surgery (MIGS) that has been safely performed since 1992. This advanced laser procedure lowers intraocular pressure (IOP) by reducing the eye’s production of aqueous humor — the fluid inside the eye.
While glaucoma is often associated with impaired fluid drainage, decreasing fluid production helps rebalance the system and effectively control eye pressure.
ECP is most commonly performed at the same time as cataract surgery (phacoemulsification), though it may also be performed independently in select cases.
During the procedure:
This direct visualization allows for exceptional precision and controlled treatment.
Unlike older cyclodestructive procedures, ECP:
Because the ocular surface remains intact, any future glaucoma procedures—if ever needed—are simpler and carry lower risk.
ECP is performed as an outpatient procedure in an ambulatory surgery center.
If successful, ECP can provide:
ECP is suitable for various forms of glaucoma, including primary open-angle glaucoma, and is especially effective for patients undergoing cataract surgery with mild to moderate disease.